Effect of cinnamon on blood glucose and lipid of Type II Diabetes.

Study of the effect of cinnamon on blood glucose levels and lipid profiles of Type II Diabetes Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170130032293N4

Enrollment

Registered

2018-03-13

Start date

2017-12-22

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus. Type 2 diabetes mellitus

Interventions

The purpose and method of work will be explained for all patients. It is also recommended to patients do not use cinnamon 15 days before and during the study.Written consent will be taken, One interv

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: The minimum duration of having diabetes mellitus should be five years The range of FBS should be 400-160 mg/dl Glycosylated hemoglobin should be upper 7% The age range should be 40 - 60 years old The patient only uses metformin to control his blood glucose

Exclusion criteria

Exclusion criteria: The patient has insulin therapy. The patient has other anti_glucose drugs or herbal medicines. The patient is pregnant /the patient is lactating mothers. The patient has allergy to cinnamon. The patient has nephropathy, hepatopathy or gastroenrtopathy. The patient has not willing to continue the study

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar levels In milligrams per deciliter, will be measured. Timepoint: Fast Blood Sugar will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and glucose level will be measured by glucose oxidase method.;The amount of glycosylated hemoglobin, which shows the average amount of blood sugar in the last three months. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and Glycosylated hemoglobin by enzymatic calorimetric method and Using commercial bionic kits, Tehran Pars Azmoon Co. is will be measured.;Serum insulin,blood serum insulin levels are measured. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and insulin level will be measured by the chemiluminescence method.;Insulin resistance. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and glucose is evaluated by glucose oxidase and insulin by the chemiluminescen	—

Measure

Time frame

Fasting blood sugar levels In milligrams per deciliter, will be measured. Timepoint: Fast Blood Sugar will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and glucose level will be measured by glucose oxidase method.;The amount of glycosylated hemoglobin, which shows the average amount of blood sugar in the last three months. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and Glycosylated hemoglobin by enzymatic calorimetric method and Using commercial bionic kits, Tehran Pars Azmoon Co. is will be measured.;Serum insulin,blood serum insulin levels are measured. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and insulin level will be measured by the chemiluminescence method.;Insulin resistance. Timepoint: This variable will be measured four times; 1- Before intervention, 2- Four weeks after the intervention, 3- Eight weeks after the intervention; 4- 12 weeks after the intervention. Method of measurement: After about ten hours of fasting, 5 cc venous blood sample from each research unit will be taken.The blood serums is then isolated and glucose is evaluated by glucose oxidase and insulin by the chemiluminescen

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactparvaneh sarani ali abadi

Islamic Azad University

spsarani@yahoo.com+98 54 3113 5570

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026